ASHPOfficial

Mainstreaming Addiction Treatment Act and What it Means For Patients

The MAT Act has been introduced in the 117th congress and would eliminate the burdensome x waiver which requires that a health care practitioner apply for a separate waiver through the DEA to dispense certain narcotic drugs (e.g., buprenorphine) for substance use disorder treatment. The MAT Act would increase treatment access for patients to medication assisted treatment and make it easier for clinicians to provide substance use disorder treatment to their patients.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Caring for Transgender People: Insight and Points of Controversy in Medication Therapy

In this feature from the 2021 Midyear Clinical Meeting, our content matter experts identify the challenges and share the solutions for transgender people navigating the healthcare system and discuss the clinical concerns and controversies in comprehensive medication management for transgender people.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Getting Started with Transitions of Care Pharmacy Services

This podcast episode provides an overview of how healthcare providers may initiate transitions of care services. Speakers share both successes and challenges experienced when implementing their own transitions of care services as well as how they were able to overcome barriers. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pneumococcal Vaccine Updates

The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recently updated the pneumococcal vaccination recommendations and guidelines to include two newly approved vaccines. The updated guidelines provide a more streamlined method for patients across age and risk groups. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy Technician Practice Vision: A Roundtable Conversation of Future Directions, Challenges, and Incentives

This podcast episode discusses strategies to improve engagement, emotional components of retention and job satisfaction, and methods to recognize the valuable role technicians provide in patient care. With the heightened national issue around healthcare burnout and how this impacts professional satisfaction and retention for pharmacy technicians this discussion provides insights how organizations have made improvements to support their pharmacy technicians.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

AJHP Voices - Telehealth Theme Issue

In this podcast episode, Dr. Tristan Maiers, Dr. Alicia Mattson, and Dr. Kristen Baron discuss their respective articles entitled, “Impact of a pharmacist-led telehealth oral chemotherapy clinic”, “Description of telepharmacy services by emergency medicine pharmacists”, and “Evaluation of a remote hybrid staffing model for ambulatory clinical pharmacists in a pediatric health system during the COVID-19 pandemic”, which were published in the AJHP theme issue on Telehealth, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Involving Your Student Society of Health-System Pharmacists (SSHP) with your State Affiliate

During this podcast, we will be talking with Tina Claypool. We will discuss her involvement with Kentucky Society of Health-System Pharmacists (KSHP) Women in Pharmacy Committee and the integration of students with state affiliates. This relationship is beneficial by encouraging professional growth, mentorship, and furthering the provision of pharmacy care. The audience will gain insight on inclusion and how to involve themselves with state affiliates. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Advantage: Standardize 4 Safety- Past, Present, and Future of Safer Care

Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago.

ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction.

Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Opportunities and Successes for Developing Patient Mental Health Support Programs

This podcast episode looks at successful patient mental health support programs and the approaches the programs used to be successful. The moderator and guests discuss methodologies and strategies that will help listeners better understand how to implement a successful patient mental health support program at their site. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Leading for Practice: Career Directions and Influencing Change

This podcast episode is a special edition as part of ASHP’s recognition of Asian-American and Pacific Islander Heritage Month. This episode provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Binita Patel, Ashley Ramp, and Chris Scott will share their insights on their professional journeys as pharmacists and association leaders. This discussion includes the value of mentors, essentials for leading teams, growing influence, and achieving personal goals. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.